These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19000593)

  • 21. Risk factors affecting arteriovenous access patency in nocturnal home hemodialysis patients
.
    Mok MYM; Chan CT
    Clin Nephrol; 2019 May; 91(5):284-293. PubMed ID: 30663973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular Access Monitoring and Surveillance: An Update.
    Valliant A; McComb K
    Adv Chronic Kidney Dis; 2015 Nov; 22(6):446-52. PubMed ID: 26524949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of the use of stent grafts to salvage failed arteriovenous accesses.
    Webb KM; Cull DL; Carsten CG; Johnson BL; Taylor SM
    Ann Vasc Surg; 2010 Jan; 24(1):34-8. PubMed ID: 19765947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Saran R; Dykstra DM; Wolfe RA; Gillespie B; Held PJ; Young EW;
    Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis.
    Dember LM; Holmberg EF; Kaufman JS
    Kidney Int; 2004 Jul; 66(1):390-8. PubMed ID: 15200448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular access surveillance: an ongoing controversy.
    Paulson WD; Moist L; Lok CE
    Kidney Int; 2012 Jan; 81(2):132-42. PubMed ID: 21975864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of transvenous cardiac devices on vascular access patency in hemodialysis patients.
    Tan CS; Jie C; Joe J; Irani ZD; Ganguli S; Kalva SP; Wicky S; Wu S
    Semin Dial; 2013; 26(6):728-32. PubMed ID: 23458207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis.
    Shafi ST; Gupta M
    J Vasc Access; 2007; 8(2):103-8. PubMed ID: 17534796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based data for the hemodialysis access surgeon.
    Huber TS; Buhler AG; Seeger JM
    Semin Dial; 2004; 17(3):217-23. PubMed ID: 15144548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upper limb grafts for hemodialysis access.
    Shemesh D; Goldin I; Verstandig A; Berelowitz D; Zaghal I; Olsha O
    J Vasc Access; 2015; 16 Suppl 9():S34-9. PubMed ID: 25751548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive methods to identify early vascular access dysfunction.
    Soule JL; Henry ML
    Semin Vasc Surg; 2007 Sep; 20(3):164-6. PubMed ID: 17884617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Clinical Relevance and Management of High-Flow Arteriovenous Access.
    Bucktowarsing B; Vin Y; Lerma EV
    Adv Chronic Kidney Dis; 2020 May; 27(3):214-218. PubMed ID: 32891305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow.
    Schwab SJ; Oliver MJ; Suhocki P; McCann R
    Kidney Int; 2001 Jan; 59(1):358-62. PubMed ID: 11135091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodialysis Arteriovenous Vascular Access Creation After Kidney Transplant Failure.
    Zhang JC; Al-Jaishi A; Perl J; Garg AX; Moist LM
    Am J Kidney Dis; 2015 Oct; 66(4):646-54. PubMed ID: 25975965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of basilic vein transposition for dialysis access.
    El Sayed HF; Mendoza B; Meier GH; LeSar CJ; DeMasi RJ; Glickman MH; Gregory RT; Parent FN; Marcinczyk MJ; Gayle RG
    Vascular; 2005; 13(5):268-74. PubMed ID: 16288701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective assessment of hemodialysis access patency after percutaneous intervention: Cox proportional hazards analysis.
    Bittl JA; Feldman RL
    Catheter Cardiovasc Interv; 2005 Nov; 66(3):309-15. PubMed ID: 16208692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence based evaluation of immuno-coagulatory interventions in critical care.
    Afshari A
    Dan Med Bull; 2011 Sep; 58(9):B4316. PubMed ID: 21893014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical management of hemodialysis-related central venous occlusive disease: a treatment algorithm.
    Anaya-Ayala JE; Bellows PH; Ismail N; Cheema ZF; Naoum JJ; Bismuth J; Lumsden AB; Reardon MJ; Davies MG; Peden EK
    Ann Vasc Surg; 2011 Jan; 25(1):108-19. PubMed ID: 21172586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review.
    Tonelli M; James M; Wiebe N; Jindal K; Hemmelgarn B;
    Am J Kidney Dis; 2008 Apr; 51(4):630-40. PubMed ID: 18371539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.